Hoag Memorial Hospital Presbyterian
hoag.orgLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
32
Active
6
Phase 3
0
Total enrollment
12,520
Pipeline matrix
Showing 4 of 4 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| DZ-002 - 5 mg/kg, 6 mg/kg, or 7 mg/kg | — | — | — | — | — | 1 | |
| Cu-NU101 | — | — | — | — | — | 1 | |
| DCFPyL PET/CT | — | — | — | — | — | 1 | |
| Copper 61-PSMA PET/CT | — | — | — | — | — | 1 |
Next readouts
- 2022-07-15
- 2025-03-31
- 2028-08-01
- 2028-11
Top conditions
- Lymphoma5
- Leukemia3
- Unspecified Adult Solid Tumor, Protocol Specific3
- Melanoma (Skin)3
- Breast Cancer3
- Pancreatic Cancer3
- Prostate Cancer3
- Multiple Myeloma and Plasma Cell Neoplasm2
Frequently asked questions about Hoag Memorial Hospital Presbyterian
- How many clinical trials does Hoag Memorial Hospital Presbyterian have on ClinicalTrials.gov?
- Hoag Memorial Hospital Presbyterian is listed as the lead sponsor on 32 clinical trials in ClinicalTrials.gov, 6 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Hoag Memorial Hospital Presbyterian's trials are in Phase 3?
- 0 of Hoag Memorial Hospital Presbyterian's trials are in Phase 3, spread across 4 active drug programs.
- What therapeutic areas does Hoag Memorial Hospital Presbyterian focus on?
- Hoag Memorial Hospital Presbyterian's most-studied conditions on ClinicalTrials.gov are Lymphoma, Leukemia, Unspecified Adult Solid Tumor, Protocol Specific, Melanoma (Skin), Breast Cancer.
- When are Hoag Memorial Hospital Presbyterian's next clinical trial readouts?
- Hoag Memorial Hospital Presbyterian has 4 upcoming primary-completion readouts tracked here; the soonest is “PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer”, expected around 2022-07-15.